Compare Becton Dickinson and Co (BDX) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Teucrium Soybean Fund — how do they compare? Becton Dickinson and Co trades at $154.99 (market cap $41.51B), while Teucrium Soybean Fund trades at $25.46. The key difference: Becton Dickinson and Co pays a 2.79% dividend while Teucrium Soybean Fund pays none, and Teucrium Soybean Fund is trading nearer its 52-week high, Becton Dickinson and Co nearer its low. Which is the better fit depends on your goals.
| BDX | SOYB | |
|---|---|---|
Market Cap | $41.51B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $185.39 | $25.36 |
52-Week Low | $135.49 | $21.07 |
Enterprise Value | $57.97B | — |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
SOYB trades at $25.33, up 0.64% on the day, with a bullish technical outlook from moving averages but neutral oscillators. The stock lacks disclosed financial ratios, and recent news highlights potential tailwinds from agricultural trade developments, including China's pledge to buy $17 billion of U.S. crops annually through 2028, which could benefit related sectors.
The stock's upside is supported by positive technical momentum and sector-specific catalysts, though the absence of fundamental data limits valuation clarity. Risks include reliance on agricultural market stability and potential volatility from commodity price swings, requiring careful assessment of upcoming earnings and guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
